Stephens Begins Coverage on CIGNA (CI)

Analysts at Stephens initiated coverage on shares of CIGNA (NYSE:CI) in a research report issued on Monday, The Fly reports. The firm set an “overweight” rating on the health services provider’s stock.

A number of other equities analysts also recently weighed in on the company. Morgan Stanley initiated coverage on CIGNA in a research note on Thursday, December 13th. They issued an “overweight” rating and a $304.00 target price on the stock. SunTrust Banks boosted their target price on CIGNA and gave the stock a “buy” rating in a research note on Thursday, September 27th. Zacks Investment Research downgraded CIGNA from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 9th. ValuEngine upgraded CIGNA from a “sell” rating to a “hold” rating in a research note on Monday, September 17th. Finally, Barclays upped their price objective on CIGNA from $228.00 to $235.00 and gave the company an “overweight” rating in a research note on Friday, November 2nd. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. CIGNA presently has an average rating of “Buy” and an average target price of $228.56.

Shares of NYSE CI opened at $194.66 on Monday. CIGNA has a twelve month low of $163.02 and a twelve month high of $227.13. The company has a market capitalization of $46.36 billion, a PE ratio of 18.61, a price-to-earnings-growth ratio of 0.80 and a beta of 0.73. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.61.

CIGNA (NYSE:CI) last announced its earnings results on Thursday, November 1st. The health services provider reported $3.84 earnings per share for the quarter, topping analysts’ consensus estimates of $3.45 by $0.39. CIGNA had a return on equity of 23.31% and a net margin of 6.15%. The firm had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.19 billion. During the same quarter in the previous year, the business earned $2.83 EPS. The company’s revenue was up 10.3% compared to the same quarter last year. On average, analysts forecast that CIGNA will post 14.28 EPS for the current fiscal year.

In other CIGNA news, insider Jason D. Sadler sold 21,189 shares of the stock in a transaction on Friday, November 2nd. The stock was sold at an average price of $212.99, for a total transaction of $4,513,045.11. Following the sale, the insider now owns 41,966 shares in the company, valued at $8,938,338.34. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director William D. Zollars sold 201 shares of the stock in a transaction on Friday, December 14th. The stock was sold at an average price of $210.84, for a total value of $42,378.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 24,215 shares of company stock worth $5,160,680. Company insiders own 1.10% of the company’s stock.

Large investors have recently bought and sold shares of the business. Edge Wealth Management LLC bought a new position in shares of CIGNA in the fourth quarter worth $46,000. Chicago Partners Investment Group LLC increased its holdings in shares of CIGNA by 31.5% in the fourth quarter. Chicago Partners Investment Group LLC now owns 3,728 shares of the health services provider’s stock worth $715,000 after purchasing an additional 894 shares during the period. YHB Investment Advisors Inc. increased its holdings in shares of CIGNA by 173.6% in the fourth quarter. YHB Investment Advisors Inc. now owns 4,008 shares of the health services provider’s stock worth $761,000 after purchasing an additional 2,543 shares during the period. Carroll Financial Associates Inc. bought a new position in shares of CIGNA in the fourth quarter worth $142,000. Finally, Acropolis Investment Management LLC bought a new position in shares of CIGNA in the fourth quarter worth $100,000. Hedge funds and other institutional investors own 93.36% of the company’s stock.

CIGNA Company Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Story: The Role of a Fiduciary and Individual Investors

The Fly

Analyst Recommendations for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply